NABP DDA: New Process & “Ineligibility Matrix”

Letter from the CEO on 2022

Letter from the CEO on 2022 Dear all, This time of year always brings a sense reflection – to understand the ups and downs of the year prior, and to plan for the year ahead. As you may know, 2021 was an amazingly transformative year for Pharma Solutions. The most...
NABP DDA: New Process & “Ineligibility Matrix”

NCDQS 2021 Recap

NCDQS 2021 Recap NCDQS has experienced extensive success in 2021, as industry and state regulating bodies recognize the value of transparency and efficiency in Accreditation and Inspection programs. Highlights include Wyoming’s approval of the QAS Accreditation...
NABP DDA: New Process & “Ineligibility Matrix”

Top SOM Insights from 2021

Top SOM Insights from 2021 The continuous development and sophistication of NavigateSOM, along with helping clients meet their objectives, pushes Pharma Solutions to stay on the cutting edge of Suspicious Order Monitoring. Insight 1 of 10: SUPPORT Act The SUPPORT Act...